Meditek Ltda.
About Meditek Ltda.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Genentech, Inc.
1
Hoffmann-La Roche
1
Idorsia Pharmaceuticals Ltd.
1
Zymeworks Inc.
1
Clinical Trials at Meditek Ltda.
During the past decade, Meditek Ltda. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
2018-12-21
2022-08-22
Completed
427
A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
2019-08-29
2024-04-30
Recruiting
362
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
2021-08-27
2033-11-21
Recruiting
4,100
A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
2021-10-05
2025-03-01
Recruiting
1,290
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Meditek Ltda.
According to Clinical.Site data, the most researched conditions in "Meditek Ltda." are
"Chronic Obstructive Pulmonary Disease" (1 trials), "Early Breast Cancer" (1 trials), "HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer" (1 trials) and "Systemic Lupus Erythematosus" (1 trials). Many other conditions were trialed in "Meditek Ltda." in a lesser frequency.
Clinical Trials Intervention Types at Meditek Ltda.
Most popular intervention types in "Meditek Ltda." are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Astegolimab" (1 trials), "Bevacizumab" (1 trials), "Capecitabine" (1 trials) and "Cenerimod 0.5 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Meditek Ltda.
The vast majority of trials in "Meditek Ltda." are
4 trials for "All" genders.
Clinical Trials Status at Meditek Ltda.
Currently, there are NaN active trials in "Meditek Ltda.".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Meditek Ltda.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Meditek Ltda., 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".